| Pinedale Medical Clinic | |
|
625 E Hennick Pinedale WY 82941 | |
| (307) 367-4133 | |
| (307) 367-6636 |
| Full Name | Pinedale Medical Clinic |
|---|---|
| Speciality | Family Medicine |
| Location | 625 E Hennick, Pinedale, Wyoming |
| Authorized Official Name and Position | Lorraine Diane Gatzke (CFO) |
| Authorized Official Contact | 3072764451 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pinedale Medical Clinic Po Box 787 Big Piney WY 83113-0787 Ph: (307) 276-4451 | Pinedale Medical Clinic 625 E Hennick Pinedale WY 82941 Ph: (307) 367-4133 |
| NPI Number | 1194776930 |
|---|---|
| Provider Enumeration Date | 05/15/2006 |
| Last Update Date | 02/10/2011 |
| Medicare PECOS PAC ID | 3476535014 |
|---|---|
| Medicare Enrollment ID | O20050708000681 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194776930 | NPI | - | NPPES |
| 121421700 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 208000000X | Pediatrics | (* (Not Available)) | Secondary |
| Provider Name | Leslie Hagenstein |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093799132 PECOS PAC ID: 4981600624 Enrollment ID: I20061019000596 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Provider Name | James P Demetriou |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447298583 PECOS PAC ID: 3779550280 Enrollment ID: I20080415000568 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Provider Name | Lance R Petersen |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1245303429 PECOS PAC ID: 3072401959 Enrollment ID: I20090205000472 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Provider Name | Charlotte R Mason |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710069273 PECOS PAC ID: 0648252585 Enrollment ID: I20110210001004 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Provider Name | Keri L Hull |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225409477 PECOS PAC ID: 6800199431 Enrollment ID: I20160114001870 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
| Provider Name | Renae Dorrity |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629293055 PECOS PAC ID: 3971657768 Enrollment ID: I20171129003221 |
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
News Archive
Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis), a swift and fatal neurodegenerative disease that paralyzes its victims.
BioCryst Pharmaceuticals, Inc. announced completion of the planned interim analysis of the peramivir Phase 3 trial in patients admitted to the hospital with serious influenza. The difference between peramivir and control groups for the primary endpoint was small and the recalculated sample size was greater than the predefined futility boundary of 320 subjects. Based on this information, the independent data monitoring committee (DMC) recommended that the study be terminated for futility.
In this post in USAID's "IMPACTblog," Heather Bergmann of John Snow Inc., who is the technical officer for USAID's AIDSTAR-One project, reports on the need to include youth in transition services for adolescents living with HIV.
› Verified 7 days ago
High Country Behavioral Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 24 Country Club Lane, Pinedale, WY 82941 Phone: 307-367-2111 Fax: 307-367-2166 | |
Pinedale Medical Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 625 E Hennick St, Pinedale, WY 82941 Phone: 307-367-4133 | |
High Country Behavioral Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 24 Country Club Lane, Pinedale, WY 82941 Phone: 307-367-2111 Fax: 307-367-2166 |